Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function

Area of Science:

• Immunology
• Respiratory Medicine
• Molecular Biology

Background:

• Hypoxia-inducible factor (HIF)-1α is a key regulator of myeloid cell inflammatory responses.
• Myeloid cells, particularly eosinophils, are central to asthma pathogenesis.
• The specific roles of HIF-1α and HIF-2α in eosinophil function during asthma remain unclear.

Purpose of the Study:

• To investigate the role of myeloid cell HIF-1α in asthma induction and pathogenesis.
• To evaluate the distinct roles of HIF-1α and HIF-2α in eosinophil chemotaxis.
• To assess the therapeutic potential of HIF-1α inhibition in an asthma model.

Main Methods:

• Utilized a myeloid cell-specific HIF-1α knockout mouse model in an ovalbumin-induced asthma model.
• Administered a pharmacological HIF-1α antagonist (YC-1) during asthma induction.
• Performed in vitro chemotaxis assays on wild-type, HIF-1α knockout, and HIF-2α knockout eosinophils.

Main Results:

• Myeloid cell HIF-1α deletion and YC-1 treatment reduced airway hyperresponsiveness (AHR) in asthma.
• HIF-1α inhibition decreased eosinophil infiltration, goblet cell hyperplasia, and key inflammatory cytokines (IL-4, IL-5, IL-13).
• HIF-1α deficiency impaired eosinophil chemotaxis, whereas HIF-2α deficiency enhanced it.

Conclusions:

• Myeloid cell HIF-1α is a critical mediator of asthma pathogenesis, particularly AHR.
• Pharmacological inhibition of HIF-1α during asthma induction effectively reduces AHR and eosinophilia.
• HIF-1α and HIF-2α exert opposing regulatory effects on eosinophil migration, highlighting their distinct roles in asthma.